Is Henry Schein Stock Underperforming the S&P 500?

Valued at a market cap of $8.8 billion, Henry Schein, Inc. (HSIC) provides healthcare products and services to dental practitioners, laboratories, physician practices, ambulatory surgery centers, government, institutional healthcare clinics, and other alternate care clinics. The Melville, New York-based company’s businesses, including Dental, Medical and Technology, and Value-Added Services, serve millions of customers worldwide. 

Companies valued at less than $10 billion are typically classified as “mid-cap stocks,” and Henry Schein fits the label perfectly. The healthcare company is recognized for its excellent customer service, highly competitive prices, and innovative value-added solutions. It co-founded the Pandemic Supply Chain Network (PSCN), a public-private partnership that helps strengthen the global health supply chain.